Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-12

Clinical Trial Update: Assessment of Potential Interactions Between Cocaine and RPR 102681 - 1 [Phase 1]

View source ↗

Summary

This clinical trial update reports on a Phase 1 study by NIDA to assess potential interactions between cocaine and the experimental compound RPR 102681.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cocaine (cocaine)
  • RPR 102681

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Cocaine-Related Disorders | Phase 1 | Status: COMPLETED